Technology and critical use issues that should be on your radar
Diseases of the tricuspid lack minimally-invasive options
Every patient, and every device is different
An increase of 286,000 over the previous year
Better predictive modeling helps tailor specific post-transplant care to each patient
The election, wearables and mergers will be top of mind for device makers this year
They say low dose radiation 'likely helps prevent' cancer
Planning the foundation of a scalable and decentralized data sharing ecosystem
New evidence that density should impact screening decisions
Danish study renews debate over value of early detection
How the ACA has been vital to rural care facilities
Tool developed by imaging policy group helps rads manage MIPS impact
Update addresses hacker vulnerabilities
Accelerating genomic insights through select collaborations
Acquisition will complement Welch Allyn business
57 percent reduction in infection rate
More research needed for FDA approval
Cybersecurity concerns and physician disinterest needs to be addressed
A look at Rep. Tom Price's advocacy track record
Government group weighs in on 'advancing high-value imaging'
Researchers point to a future without pacemaker battery replacements
Drastic reductions in prostate, breast, lung and colorectal cancer mortality
Jury award reduced from $1 billion to $500 million
Quality of care wasn't compromised
Goal is to cut down on operating losses and save about $120 million
The same thing that gives them their bite may also inhibit breast cancer growth
Patient-specific model mimics physiology of artificial valve pressure response
NIH awards $5 million grant
Alleges company violated antitrust regulations
But a trend toward patient access to reports and face time is emerging
Patient a day late for appointment tips off researchers
Creating a smaller, more affordable proton solution
Has the potential to prevent vision loss
Breast cancer targeting probes are showing promise in clinical trials
Appoints new CEO of McKesson Canada
Possible flaw in reimbursement model outlined
'Annual screening of women over 40 is the way to save the most lives'
Combined portfolio expected to hit $8.7 billion in sales annually
Noninvasive technology examines tau proteins
Shares have fallen 40 percent since Tuesday